Homepage

Stories / Global Impact

A novel therapy may free some transplant patients from having to take immunosuppressant drugs for...

Stories / Hope

Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's...

Stories / Global Impact

Novartis worked with doctors, patients and government officials in the Yaroslavl region of Russia to...

Explore Novartis

Recent Updates

Featured / 21 Jul

Novartis announces second quarter results

Novartis delivered solid performance and strong pipeline progress with major approvals and key launches.

US ONLY: #CIUandYou strives to educate about CIU, a form of chronic hives. Check out our campaign resources: http://t.co/D7jani7VQs 1 hour 1 min ago
Our Business

Novartis focuses its business on three leading divisions with strong innovation power and global scale: pharmaceuticals, eye care and generics.